Medical network - on February 6, there are two things that most drug firms batty, one is the rising production costs, is a bidding price down. When the production of the necessary raw materials and bidding price exceeds the enterprise bear the bottom line, extreme.
On February 4, who in liaoning province development planning commission issued the no. 1 of 2017 drug shortage notice warning forecast. For 10 ~ 12 in 2016 medical institutions at all levels of liaoning province reported article 53 shortage of drug information, part of the supply has been restored, and some drugs can't supply.
This time, liaoning who planning commission will be released and can't supply these products. After combing, found that drug companies can't supply the main two reasons:
▍ shortage of raw material, can't normal production
Said can't normal production of medicine with a total of nine, has seven drug firms give reason is: raw material shortage. To the problem of the shortage of raw materials rose, the blue parker did in earlier reports, and in-depth discussion of the industry.
Through the long-term observation of the industry as well as comprehensive positive feedback from readers, can outline a clear industry profile: raw materials in a period of time, become a prominent problem in drug firms.
▍ the bid price is low, drug firms out of stock
Feedback and 10 kinds of drugs, raw material prices, production line modification, increased costs, supply price is higher than the price in liaoning province, thus unable to price according to the normal supply.
▍ patients lack of drugs, drug companies, both
Liaoning health development planning commission, said in the notice for not according to the price timely, full specified amount in the supply of seven production enterprises to give warning, if happen again in violation of prices or through control pin means not the behavior of the supply timely, full specified amount, after ascertained that will be incorporated in the liaoning province pharmaceutical sales credit record.
Warning drug firms at the same time, the circumstances are serious, cancel all the enterprise products bidding qualification, 2 years should not join any drug centralized purchasing activities within the territory of liaoning province, the provincial medical institutions also can not to its 2 years purchasing any drugs.
Products for patients with no cure, drug companies have been duly punished lost the entire province market, it seems to be a lose-lose result. Objective said, drug firms under the control of the pressure of rising costs, stop-loss, is also a necessity choice, in order to guarantee the operation of the medical institutions and departments to make the punishment, is necessary.
In this game there is no right or wrong, to participate in the grievances of all parties. Why cannot seem to make is, tight bidding policy, promotion mode, health care, doctors' income, environmental pressure, labor costs and so on factors, even hard to shake off.
However, one thing is clear, if the drug firms't cut, the relation between the cost and return similar drug shortage, the phenomenon of foreclosures will happen. |
